Open Forum

Access considerations for a COVID-19 vaccine for South Africa

Varsha Bangalee, Fatima Suleman
South African Family Practice | Vol 62, No 1 : Part 4| a5152 | DOI: https://doi.org/10.4102/safp.v62i1.5152 | © 2020 Varsha Bangalee, Fatima Suleman | This work is licensed under CC Attribution 4.0
Submitted: 30 May 2020 | Published: 29 October 2020

About the author(s)

Varsha Bangalee, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
Fatima Suleman, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa


Share this article

Bookmark and Share

Abstract

The novel coronavirus (COVID-19) pandemic is a defining point in human history, having far-reaching effects on all aspects of human life. In the race to find a vaccine, governments need to work collectively to ensure that any life-saving interventions are accessible and affordable to populations across the globe. This pandemic has created an opportunity for international cooperation in working on transparency issues both in terms of sharing manufacturing details to make devices for the diagnosis and treatment of COVID-19 and in terms of clinical trials for therapies that could prove to be effective against the disease.

Keywords

COVID-19; pandemic; vaccines; pricing; transparency resolution

Metrics

Total abstract views: 505
Total article views: 344


Crossref Citations

No related citations found.